Moderna Inc (MRNA)
$136.52-4.38%previous session's close (28 Aug 2026) — awaiting today's first price update
Spriggl Score: Weak— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Melanoma trial success and flu vaccine approval fuel a rally, yet shares now trade well above analyst targets and the cash burn continues.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Moderna Inc
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- $53.2B
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Moderna Inc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free